StockData
Medtronic plc logo

Medtronic plc (MDT) operating KPIs

MDTNYSEElectromedical & Electrotherapeutic ApparatusFiscal year ends April 24
Financials through Q1 FY2027, quarter ended Jul 31, 2026Last filing: 10-Q on Sep 3, 2026Score 19/303% below fair value
$96.54−0.57 (-0.59%)

Close on Oct 30, 2026Market cap $123.49BP/E 23.7Yield 2.94%

Medtronic diabetes Portfolio (Consolidated Segment) — U.S. Organic Revenue Growth YoY (%) (%)

Medtronic Form 8-K U.S. Revenue Tables

QuarterlyAnnual
Latest, Q1 FY27
10.6%
Period ended Jul 31, 2026
Change on a year earlier
+9.7 pts
0.9% in Q1 FY26
History
20 quarters
Since Q3 FY16
Sources
20
Documents cited below

Quarterly history

Hover a value to see the sentence it was read from; calculated values show their formula

PeriodEndedDiabetes Portfolio (Consolidated Segment) — U.S. Organic Revenue Growth YoY (%) (%)Year on yearSource
Q1 FY27Jul 31, 202610.6%+9.7 ptsMedtronic SEC 8K_EARNINGS — FY2027Q1 (filed 2026-09-01) ↗
Q4 FY26Apr 30, 2026-0.2%-7.4 ptsMedtronic SEC 8K_EARNINGS — FY2026Q4 (filed 2026-06-03) ↗
Q3 FY26Jan 31, 20264.9%-0.7 ptsMedtronic SEC 8K_EARNINGS — FY2026Q3 (filed 2026-02-17) ↗
Q2 FY26Oct 31, 2025-0.8%-7.7 ptsMedtronic SEC 8K_EARNINGS — FY2026Q2 (filed 2025-11-18) ↗
Q1 FY26Jul 31, 20250.9%-13.4 ptsMedtronic SEC 8K_EARNINGS — FY2026Q1 (filed 2025-08-19) ↗
Q4 FY25Apr 30, 20257.2%-4.9 ptsMedtronic SEC 8K_EARNINGS — FY2025Q4 (filed 2025-05-21) ↗
Q3 FY25Jan 31, 20255.6%+1.4 ptsMedtronic SEC 8K_EARNINGS — FY2025Q3 (filed 2025-02-18) ↗
Q2 FY25Oct 31, 20246.9%+11.7 ptsMedtronic SEC 8K_EARNINGS — FY2025Q2 (filed 2024-11-19) ↗
Q1 FY25Jul 31, 202414.3%+23.0 ptsMedtronic SEC 8K_EARNINGS — FY2025Q1 (filed 2024-08-20) ↗
Q4 FY24Apr 30, 202412.1%+18.7 ptsMedtronic SEC 8K_EARNINGS — FY2024Q4 (filed 2024-05-23) ↗
Q3 FY24Jan 31, 20244.2%–Medtronic SEC 8K_EARNINGS — FY2024Q3 (filed 2024-02-20) ↗
Q2 FY24Oct 31, 2023-4.8%–Medtronic SEC 8K_EARNINGS — FY2024Q2 (filed 2023-11-21) ↗
Q1 FY24Jul 31, 2023-8.7%–Medtronic SEC 8K_EARNINGS — FY2024Q1 (filed 2023-08-22) ↗
Q4 FY23Apr 30, 2023-6.6%–Medtronic SEC 8K_EARNINGS — FY2023Q4 (filed 2023-05-25) ↗
Q1 FY19Jul 31, 201833.0%–Medtronic SEC 8K_EARNINGS — FY2019Q1 (filed 2018-08-21) ↗
Q4 FY18Apr 30, 201822.0%–Medtronic SEC 8K_EARNINGS — FY2018Q4 (filed 2018-05-24) ↗

Cite this data

StockData. (2026). Medtronic Diabetes Portfolio (Consolidated Segment) — U.S. Organic Revenue Growth YoY (%) (%), quarterly Q3 FY16–Q1 FY27 [Data set]. Compiled from Medtronic SEC filings and investor materials. https://stockdatahq.com/stocks/mdt/kpis/diab-seg-us-org

See every metric in the Medtronic KPI table. Data updated Oct 31, 2026.